Loading
Loading…
Loading…
| # | Company | Amount | Rank | Status |
|---|---|---|---|---|
| 1 | L1₹1 LAccepted-AOC | ₹1 L | L1 | Accepted-AOC Details in notice |
| 2 | L1₹1 LAccepted-AOC | ₹1 L | L1 | Accepted-AOC Details in notice |
| 3 | L1₹1 LAccepted-AOC | ₹1 L | L1 | Accepted-AOC Details in notice |
| 4 | L1₹1 LAccepted-AOC CIPLA HOUSE PENINSULA BUSINESS PARK GANPATRAO KADAM MARG LOWER PAREL MUMBAI MAHARASHTRA 400013 | MUMBAI | MAHARASHTRA | 400013 | ₹1 L | L1 | Accepted-AOC Details in notice |
| 5 | L1₹1 LAccepted-AOC | ₹1 L | L1 | Accepted-AOC Details in notice |
| Sl No | Description | Qty | Unit | TORRENT PHARMACEUTICALS LTD L1 | Unicure India Ltd L5 | BOEHRINGER INGELHEIM I PVT LTD L8 | CIRON DRUGS AND PHARMACEUTICALS PVT LTD L3 | Cipla Ltd L4 | AbbVie Healthcare India Private Limited L7 | Pfizer Limited L6 | Brooks Laboratories Limited L2 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.00 | ALTEPLASE INJ 50 mg | 787 | Vial | - | - | 30,227.4 ₹33,854.69 Lowest | - | - | - | - | - |
| 2.00 | AMPHOTERICIN B LIPOSOMAL INJ 50 mg | 9,294 | Vial | - | - | - | - | - | - | - | - |
| 3.00 | BOTULINUM TOXIN A INJ (FREEZE-DRIED POWDER FOR INJECTION) 50 Units | 628 | Vial | - | - | - | - | - | 6,137 ₹6,443.85 Lowest | - | - |
| 4.00 | CEFTAZIDIME AND AVIBACTAM INJ Each vial contains Ceftazidime pentahydrate equivalent to Ceftazidime 2 g and Avibactam sodium equivalent to avibactam 0.5 g | 8,681 | Vial | - | - | - | - | - | - | 2,862 ₹3,205.44 Lowest | - |
| 5.00 | CLOPIDOGREL+ASPIRIN TAB IP 75 mg + 75 mg | 16,82,162 | 1 No | 2.03 ₹2.27 Lowest | - | - | - | - | - | - | - |
| 6.00 | DYDROGESTERONE TAB IP 10 mg | 43,000 | 1 No | - | - | - | - | - | - | - | - |
| 7.00 | FLUVOXAMINE TAB IP 100 mg | 1,15,154 | 1 No | - | - | - | - | - | - | - | - |
| 8.00 | FORMOTEROL FUMARATE AND BUDESONIDE INHALER 6 mcg + 200 mcg | 8,41,797 | 120 MD | - | - | - | - | 64.48 ₹7.74 Lowest | - | - | - |
| 9.00 | ITRACONAZOLE TAB 200 mg | 85,200 | 1 No | - | 14.18 ₹1.7 Lowest | - | - | - | - | - | - |
| 10.00 | LACTULOSE ENEMA 20% w/v | 18,945 | 275 ml | - | 183.2 ₹9.16 Lowest | - | - | - | - | - | - |
Tender Value
Refer Docs
EMD Value
₹50,000
Closing Date
30 Jul 2025, 5:00 pmClosed
Managing Director
KMSCL, THYCAUD
Re-tender for the procurement of specialty drugs for the year 2025-26
2025_KMSCL_777243_1
KMSCL/ED/SPL/RT/2025/020
Open Tender
Medicines
Item Wise
365 days
Thiruvananthapuram
Please refer tender document
21 documents required · 21 mandatory
₹29,500
Yes
₹50,000
Yes
online platform
4 Jun 2026
16 Jul 2025
1 Aug 2025
16 Jul 2025
30 Jul 2025
16 Jul 2025
16 Jul 2025 - 30 Jul 2025
21 Jul 2025
ALTEPLASE INJ 50 mg
AMPHOTERICIN B LIPOSOMAL INJ 50 mg
BOTULINUM TOXIN A INJ (FREEZE-DRIED POWDER FOR INJECTION) 50 Units
CEFTAZIDIME AND AVIBACTAM INJ Each vial contains Ceftazidime pentahydrate equivalent to Ceftazidime 2 g and Avibactam sodium equivalent to avibactam 0.5 g
CLOPIDOGREL+ASPIRIN TAB IP 75 mg + 75 mg
DYDROGESTERONE TAB IP 10 mg
FLUVOXAMINE TAB IP 100 mg
FORMOTEROL FUMARATE AND BUDESONIDE INHALER 6 mcg + 200 mcg
ITRACONAZOLE TAB 200 mg
LACTULOSE ENEMA 20% w/v
LEVETIRACETAM ORAL SOLUTION IP 100 mg/ml
OCTREOTIDE INJ 100 mcg/ml
SILODOSIN CAP 8 mg
SODIUM BICARBONATE TAB IP 500 mg
VENLAFAXINE PROLONGED RELEASE CAP IP 75 mg
VORICONAZOLE TAB IP 200 mg
Brooks Laboratories Limited (BID ID -2260995)
CIRON DRUGS AND PHARMACEUTICALS PVT LTD (BID ID -2259273)
Cipla Ltd (BID ID -2267063)
Unicure India Ltd (BID ID -2254894)
Pfizer Limited (BID ID -2266305)
AbbVie Healthcare India Private Limited (BID ID -2259863)
BOEHRINGER INGELHEIM I PVT LTD (BID ID -2257571)
stage.html
html • 0.07 MB
tech_eval.pdf
boq_comp_chart.xlsx
xlsx
fin_eval.pdf
aoc.pdf
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
details.html
html • 0.04 MB
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .